Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #231339 on Amarin Corp Plc (AMRN)
bfost
12/03/19 5:51 PM
#231344 RE: sts66 #231339
Atom0aks
12/03/19 6:18 PM
#231353 RE: sts66 #231339
Doc, I copied that directly from the AC voting question PDF - AMRN did not ask for a label from FDA that contains the word "statins"
DISCUSSION: The applicant has proposed an indication for cardiovascular risk reduction in adult patients with triglyceride levels greater than 135 mg/dL and additional risk factors for cardiovascular disease (CVD), without regard for age, diabetes status, or adequacy of low-density lipoprotein (LDL-C) control. Please discuss the population – beyond the subset of patients with established CVD – for whom you believe the data from REDUCE-IT provide evidence of cardiovascular risk benefit, addressing the following factors: • Age • Diagnosis of diabetes • Additional risk factors for CVD • Plasma LDL-C concentration • Plasma triglyceride concentration • Intensity of statin therapy • Any other factor you believe is important